The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Serum and Urine Metabolite Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma
Open accessAbstract
Hepatocellular carcinoma (HCC) is a common malignancy in the world with high morbidity and mortality rate. Identification of novel biomarkers in HCC remains impeded primarily because of the heterogeneity of the disease in clinical presentations as well as the pathophysiological variations derived from underlying conditions such as cirrhosis and steatohepatitis. The aim of this study is to search for potential metabolite biomarkers of human HCC using serum and urine metabolomics approach. Sera and urine samples were collected from patients with HCC (n = 82), benign liver tumor patients (n = 24), and healthy controls (n = 71). Metabolite profiling was performed by gas chromatography time-of-flight mass spectrometry and ultra performance liquid chromatography-quadrupole time of flight mass spectrometry in conjunction with univariate and multivariate statistical analyses. Forty three serum metabolites and 31 urinary metabolites were identified in HCC patients involving several key metabolic pathways such as bile acids, free fatty acids, glycolysis, urea cycle, and methionine metabolism. Differentially expressed metabolites in HCC subjects, such as bile acids, histidine, and inosine are of great statistical significance and high fold changes, which warrant further validation as potential biomarkers for HCC. However, alterations of several bile acids seem to be affected by the condition of liver cirrhosis and hepatitis. Quantitative measurement and comparison of seven bile acids among benign liver tumor patients with liver cirrhosis and hepatitis, HCC patients with liver cirrhosis and hepatitis, HCC patients without liver cirrhosis and hepatitis, and healthy controls revealed that the abnormal levels of glycochenodeoxycholic acid, glycocholic acid, taurocholic acid, and chenodeoxycholic acid are associated with liver cirrhosis and hepatitis. HCC patients with alpha fetoprotein values lower than 20 ng/ml was successfully differentiated from healthy controls with an accuracy of 100% using a panel of metabolite markers. Our work shows that metabolomic profiling approach is a promising screening tool for the diagnosis and stratification of HCC patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999) · Xenobiotica · doi:10.1080/004982599238047 · Cited by 3,895
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., et al. (2009) · Nature · doi:10.1038/nature07762 · Cited by 2,234
Wiklund, S., Johansson, E., Sjöström, L., Mellerowicz, E. J., Edlund, U., Shockcor, J. P., Gottfries, J., Moritz, T., & Trygg, J. (2008) · Analytical Chemistry · doi:10.1021/ac0713510 · Cited by 1,233
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
El-serag, H. B., Tran, T., & Everhart, J. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.065 · Cited by 1,230
Colli, A., Fraquelli, M., Casazza, G., Massironi, S., Colucci, A., Conte, D., & Duca, P. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00467.x · Cited by 540
Metabolomics Reveals Metabolic Biomarkers of Crohn's Disease
Jansson, J., Willing, B., Lucio, M., Fekete, A., Dicksved, J., Halfvarson, J., Tysk, C., & Schmitt-Kopplin, P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006386 · Cited by 512
Chan, E. C. Y., Koh, P. K., Mal, M., Cheah, P. Y., Eu, K. W., Backshall, A., Cavill, R., Nicholson, J. K., & Keun, H. C. (2009) · Journal of Proteome Research · doi:10.1021/pr8006232 · Cited by 444
Jonsson, P., Johansson, A. I., Gullberg, J., Trygg, J., A, J., Grung, B., Marklund, S., Sjöström, M., Antti, H., & Moritz, T. (2005) · Analytical Chemistry · doi:10.1021/ac050601e · Cited by 426
Serum Metabolite Profiling of Human Colorectal Cancer Using GC−TOFMS and UPLC−QTOFMS
Qiu, Y., Cai, G., Su, M., Chen, T., Zheng, X., Xu, Y., Ni, Y., Zhao, A., Xu, L. X., Cai, S., et al. (2009) · Journal of Proteome Research · doi:10.1021/pr9004162 · Cited by 395
Self-citationDenkert, C., Budczies, J., Kind, T., Weichert, W., Tablack, P., Sehouli, J., Niesporek, S., Könsgen, D., Dietel, M., & Fiehn, O. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0755 · Cited by 378
A Strategy for Identifying Differences in Large Series of Metabolomic Samples Analyzed by GC/MS
Jonsson, P., Gullberg, J., Nordström, A., Kusano, M., Kowalczyk, M., Sjöström, M., & Moritz, T. (2004) · Analytical Chemistry · doi:10.1021/ac0352427 · Cited by 349
Metabolite profiling of human colon carcinoma – deregulation of TCA cycle and amino acid turnover
Denkert, C., Budczies, J., Weichert, W., Wohlgemuth, G., Scholz, M., Kind, T., Niesporek, S., Noske, A., Buckendahl, A., Dietel, M., et al. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-72 · Cited by 317
Lewis, G. D., Wei, R., Liu, E., Yang, E., Shi, X., Martinovic, M., Farrell, L., Asnani, A., Cyrille, M., Ramanathan, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35111 · Cited by 283
Yang, Y., Li, C., Nie, X., Feng, X., Chen, W., Yue, Y., Tang, H., & Deng, F. (2007) · Journal of Proteome Research · doi:10.1021/pr070063h · Cited by 233
Gao, H., Lu, Q., Liu, X., Cong, H., Zhao, L., Wang, H., & Lin, D. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01086.x · Cited by 194
Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers
Woo, H. M., Kim, K. M., Choi, M. H., Jung, B. H., Lee, J., Kong, G., Nam, S. J., Kim, S., Bai, S. W., & Chung, B. C. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.10.014 · Cited by 182
Ni, Y., Su, M., Lin, J., Wang, X., Qiu, Y., Zhao, A., Chen, T., & Jia, W. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.06.040 · Cited by 173
Self-citationUltra‐performance LC/TOF MS analysis of medicinal Panax herbs for metabolomic research
Xie, G., Plumb, R., Su, M., Xu, Z., Zhao, A., Qiu, M., Long, X., Liu, Z., & Jia, W. (2008) · Journal of Separation Science · doi:10.1002/jssc.200700650 · Cited by 169
Self-citationda Silva, R. P., Nissim, I., Brosnan, M. E., & Brosnan, J. T. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90547.2008 · Cited by 160
Qiu, Y., Su, M. M., Liu, Y., Chen, M., Gu, J., Zhang, J., & Jia, W. P. (2006) · Analytica Chimica Acta · doi:10.1016/j.aca.2006.10.025 · Cited by 158
Self-citationCoston, W. M. P., Loera, S., Lau, S. K., Ishizawa, S., Jiang, Z., Wu, C., Yen, Y., Weiss, L. M., & Chu, P. G. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318158142f · Cited by 153
Self-citationHepatocellular carcinoma: an overview
Anthony, P. P. (2001) · Histopathology · doi:10.1046/j.1365-2559.2001.01188.x · Cited by 142
Characterization of Pu-erh Tea Using Chemical and Metabolic Profiling Approaches
Xie, G., Ye, M., Wang, Y., Ni, Y., Su, M., Huang, H., Qiu, M., Zhao, A., Zheng, X., Chen, T., et al. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf804000y · Cited by 136
Self-citationXue, R., Lin, Z., Deng, C., Dong, L., Liu, T., Wang, J., & Shen, X. (2008) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.3708 · Cited by 105
Ni, Y., Su, M., Qiu, Y.-P., Chen, M.-J., Liu, Y., Zhao, A., & Jia, W. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.01.036 · Cited by 100
Self-citationYan, S.-K., Wei, B.-J., Lin, Z.-Y., Yang, Y., Zhou, Z.-T., & Zhang, W.-D. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2007.06.007 · Cited by 95
Mavri‐Damelin, D., Eaton, S. D., Damelin, L. H., Rees, M., Hodgson, H. J. F., & Selden, C. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.10.007 · Cited by 88
Liver resection and transplantation in the management of hepatocellular carcinoma: a review.
Kassahun, W. T., Fangmann, J., Harms, J., Hauss, J., & Bartels, M. J. (2006) · PubMed · Cited by 61
Cited by
Zheng, P., Zeng, B., Zhou, C., Liu, M., Fang, Z., Xu, X., Zeng, L., Chen, J., Fan, S., Du, X., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.44 · Cited by 2,023
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Jia, W., Xie, G., & Jia, W. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.119 · Cited by 1,924
Self-citationThévenot, E. A., Roux, A., Xu, Y., Ezan, E., & Junot, C. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00354 · Cited by 1,735
From NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392
Advances in the Early Diagnosis of Hepatocellular Carcinoma
Wang, W., & Wei, C. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.01.014 · Cited by 492
Metadata
- Authors
- Chen, T., Xie, G., Wang, X., Fan, J., Qiu, Y., Zheng, X., Qi, X., Cao, Y., Su, M., Wang, X., Xu, L. X., Yen, Y., Liu, P., & Jia, W.
- Venue
- Molecular & Cellular Proteomics
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 10
- Issue
- 7
- Pages
- M110.004945
- ISSN
- 1535-9476 (ISSN-L)
- OpenAlex
- W2126591541
- Cited by
- 357
- References
- 30
- FWCI
- 10.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.